US Patent Issued to Salix Pharmaceuticals on Aug. 25 for "Solid dispersion forms of rifaximin" (North Carolina Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,699, issued on Aug. 25, was assigned to Salix Pharmaceuticals Inc. (Bridgewater, N.J.).

"Solid dispersion forms of rifaximin" was invented by Pam Golden (Durham, N.C.) and Mohammed A. Kabir (Cary, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof."

The patent was filed on Aug. 14, 2025, under Application No. 19/299,544.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=127146...